About: A placebo-controlled trial of Korean red ginseng extract for preventing Influenza-like illness in healthy adults

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A placebo-controlled trial of Korean red ginseng extract for preventing Influenza-like illness in healthy adults Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	A placebo-controlled trial of Korean red ginseng extract for preventing Influenza-like illness in healthy adults
Creator	Back, Hyang-Im Chae, Soo-Wan Choi, Eun-Kyung Choi, Kyung-Min Ha, Ki-Chan Kang, Hee-Joo Kim, Min-Gul Kim, Min-Jeong Kim, Sun-Young Kwon, Dae-Young Lee, Chang-Seop Lee, Ju-Hyung Oh, Mi-Ra Park, Eun-Ok Yang, Hye-Jeong
Source	Medline; PMC
abstract	ABSTRACTS: BACKGROUND: Standardized Korean red ginseng extract has become the best-selling influenza-like illness (ILI) remedy in Korea, yet much controversy regarding the efficacy of the Korean red ginseng (KRG) in reducing ILI incidence remains. The aim of the study is to assess the efficacy of the KRG extract on the ILI incidence in healthy adults. METHODS/DESIGN: We will conduct a randomized, double-blind, placebo-controlled study at the onset of the influenza seasons. A total of 100 subjects 30-70 years of age will be recruited from the general populations. The subjects will be instructed to take 9 capsules per day of either the KRG extract or a placebo for a period of 3 months. The primary outcome measure is to assess the frequency of ILI onset in participated subjects. Secondary variable measures will be included severity and duration of ILI symptoms. The ILI symptoms will be scored by subjects using a 4-point scale. DISCUSSION: This study is a randomized placebo controlled trial to evaluate the efficacy of the KRG extract compared to placebo and will be provided valuable new information about the clinical and physiological effects of the KRG extract on reduction of ILI incidence including flu and upper respiratory tract infections. The study has been pragmatically designed to ensure that the study findings can be implemented into clinical practice if KRG extract can be shown to be an effective reduction strategy in ILI incidence. TRIAL REGISTRATION: NCT01478009.
has issue date	2012-02-08(xsd:dateTime)
bibo:doi	10.1186/1472-6882-12-10
bibo:pmid	22314101
has license	cc-by
sha1sum (hex)	5d7698a990270f5ebfa2c879d56187116acc7646
schema:url	https://doi.org/10.1186/1472-6882-12-10
resource representing a document's title	A placebo-controlled trial of Korean red ginseng extract for preventing Influenza-like illness in healthy adults
has PubMed Central identifier	PMC3297520
has PubMed identifier	22314101
schema:publication	BMC Complement Altern Med
resource representing a document's body	covid:5d7698a990270f5ebfa2c879d56187116acc7646#body_text
is schema:about of	named entity 'PLACEBO-CONTROLLED TRIAL' named entity 'KRG' named entity 'KRG' named entity 'Secondary' named entity 'The' named entity 'remains' named entity 'adults' named entity 'extract' named entity 'AGE' named entity 'INCLUDING' named entity 'COMPARED' named entity 'STRATEGY' named entity 'PERIOD' named entity 'CONTROLLED TRIAL' named entity 'POPULATIONS' named entity 'BACKGROUND' named entity 'PRIMARY OUTCOME MEASURE' named entity 'REMEDY' named entity 'FLU' named entity 'EFFECTIVE' named entity 'GENERAL' named entity 'ILI' named entity 'BEST' named entity 'SELLING' named entity 'NEW INFORMATION' named entity 'SEASONS' named entity 'ONSET OF' named entity 'METHODS' named entity 'SECONDARY' named entity 'VARIABLE' named entity 'MUCH' named entity 'SEVERITY' named entity 'AIM' named entity 'ADULTS' named entity 'IMPLEMENTED' named entity 'DURATION' named entity 'YEARS' named entity 'ENSURE' named entity 'ONSET' named entity 'GINSENG EXTRACT' named entity 'KOREAN' named entity 'GINSENG' named entity 'EXTRACT' named entity 'PHYSIOLOGICAL EFFECTS' named entity 'CLINICAL' named entity 'INFLUENZA-LIKE ILLNESS' named entity 'CONDUCT' named entity 'PLACEBO' named entity 'EITHER' named entity 'EVALUATE' named entity 'RED' named entity 'INFLUENZA' named entity 'SYMPTOMS' named entity 'KOREAN' named entity 'PREVENTING' named entity 'HEALTHY' named entity 'ADULTS' named entity 'EFFICACY' named entity 'BLIND' named entity 'GINSENG EXTRACT' named entity 'PROVIDED' named entity 'FINDINGS' named entity 'RED' named entity 'PER DAY' named entity 'DISCUSSION' named entity 'REDUCING' named entity 'UPPER RESPIRATORY TRACT INFECTIONS'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software